AndreaBozzo/ceres-open-data-index huggingface dataset:
Venous oxygen measurements in the inferior vena cava in neonates with respiratory failure

Background:
          The present study was undertaken to examine the feasibility of venous oxygen measurements in the inferior vena cava (IVC) via a catheter through the umbilical vein. This may serve as a proxy for mixed venous oxygenation and the complications of right atrial cannulation can be avoided at the same time. It has the added advantage of not being affected by atrial right-left shunting.
        
        
          Results:
          The study included 22 neonates requiring mechanical ventilation for respiratory insufficiency. The success rate of catheterization of the IVC via the umbilical vein was 81% and there was no catheter-related complications. Fifty paired blood samples were obtained and analyzed while the patients were hemodynamically stable. Linear regression analysis showed a poor correlation between arterial oxygen tension (PaO2) and the arterial-venous oxygen content difference [C(a–v)O2], r = -0.005, and between PaO2 and the fractional oxygen extraction (FOE), r = -0.114. There was also a poor correlation between arterial oxygen saturation (SaO2) and C(a–v)O2, r = -0.057, and between SaO2 and FOE, r =-0.139. The correlations between venous oxygen tension (PvO2) and C(a–v)O2 and between PvO2 and FOE were r = -0.528 and r = 0.592, respectively. There were good correlations between various oxygen saturation (SvO2) and C(a–v)O2, r = -0.634, and between SvO2 FOE, r = -0.712.
        
        
          Conclusion:
          Venous oxygen measurement in the IVC via an umbilical vein catheter is a simple and safe procedure and provides information about the tissue oxygenation status of critically ill neonates.
SACWIS Technical Bulletin #1: Action Plan Guidance and Examples

This Technical Bulletin provides guidance for states developing action plans for the Statewide Automated Child Welfare Information System (SACWIS) Assessment Review Report (SARR). States submit action plans to describe to the Administration for Children and Families (ACF) their approach for bringing the SACWIS into compliance with federal requirements.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 527550: 1,3-Cyclohexadiene, 1-iodo-2-methyl

Chemical compound data from PubChem database. IUPAC Name: 1-iodo-2-methylcyclohexa-1,3-diene. Molecular Formula: C7H9I. Molecular Weight: 220.05. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2014 Mental Health Client-Level Data Report (MH-CLD)

This report presents results from the Mental Health Client Level Data (MH-CLD) and Mental Health Treatment Episode Set (MH-TEDS) for individuals receiving mental health treatment services in 2014, as well as selected data collection trends for such individuals from 2011 to 2014. The report provides information on mental health diagnoses, mental health treatment services, and demographic and substance use characteristics of individuals in mental health treatment in facili-ties that reported to individual state administrative data systems. One chapter is also devoted to characteristics of admissions to and discharges from mental health treatment, which can feature the same individual on multiple occasions.
Patent AT-E400655-T1: [Translated] POLYNUCLEOTIDE SYNTHESIS USING PROCESSING ENZYME

The present invention pertains to a method for polynucleotide synthesis, comprising the steps of: (i) reacting a polynucleotide processive enzyme, e.g., a polymerase or TdT, with a nucleotide substrate under conditions suitable for enzyme activity; and (ii) modulating the conformation of the enzyme, e.g. using radiation, to allow incorporation of a predetermined nucleotide.
Compound 529091: (5E)-3-(2-Methoxyphenyl)-2-thioxo-1,3-thiazolidine-4,5-dione 5-oxime

Chemical compound data from PubChem database. IUPAC Name: 11-methyl-1,8-diazatricyclo[7.4.0.03,7]trideca-3,6,8,10,12-pentaen-2-one. Molecular Formula: C12H10N2O. Molecular Weight: 198.22. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Practising evidence-based medicine: the design and implementation of a multidisciplinary team-driven extubation protocol

Background
          Evidence from recent literature shows that protocol-directed extubation is a useful approach to liberate patients from mechanical ventilation (MV). However, research evidence does not necessarily provide guidance on how to implement changes in individual intensive care units (ICUs). We conducted the present study to determine whether such an evidence-based strategy can be implemented safely and effectively using a multidisciplinary team (MDT) approach.
        
        
          Method
          We designed a MDT-driven extubation protocol. Multiple meetings were held to encourage constructive criticism of the design by attending physicians, nurses and respiratory care practitioners (RCPs), in order to define a protocol that was evidence based and acceptable to all clinical staff involved in the process of extubation. It was subsequently implemented and evaluated in our medical/ surgical ICU. Outcomes included response of the MDT to the initiative, duration of MV and stay in the ICU, as well as reintubation rate.
        
        
          Results
          The MDT responded favourably to the design and implementation of this MDT-driven extubation protocol, because it provided greater autonomy to the staff. Outcomes reported in the literature and in the historical control group were compared with those in the protocol group, and indicated similar durations of MV and ICU stay, as well as reintubation rates. No adverse events were documented.
        
        
          Conclusion
          An MDT approach to protocol-directed extubation can be implemented safely and effectively in a multidisciplinary ICU. Such an effort is viewed favourably by the entire team and is useful in enhancing team building.
Elk Creek Seismic Waveforms 2012 (Part 7 of 20)

Coal bursts (damaging seismic events in underground coal mines) pose a substantial threat to operations and mine workers. The underground coal mines in Colorado’s North Fork Valley (NFV) have experienced many coal bursts, often with distinct characteristics from those of other US coal mining regions. To better understand these events and manage their associated risks, the National Institute for Occupational Safety and Health undertook a long-term monitoring campaign at the Elk Creek Mine in the NFV. The monitoring efforts included a seismic network composed of both surface and underground sensors, borehole pressure cells (BPCs), instrumented support Cans, convergence monitors, ground condition surveys, and several other data sources. This dataset consists of the event waveform files from the seismic network for the 983,379 events that were detected during the monitoring campaign. The waveforms are stored in HDF5 files that are broken up by week. Within the HDF5 files, the data are organized by station id, event time, and channel. The amplitudes are velocity in meters/second.
 
This is download 34 of 48 and corresponds to the time range between April 23, 2012, and May 28, 2012.
Patent AT-E401230-T1: [Translated] ROAD SWEEPING MACHINE WITH ELECTRIC STEERING AND RELATIVE CONTROL SYSTEM

The self-propelled sweeper with electrical steering comprises a frame suitable for receiving the refuse container (13), waste collection and suction members (2; 4, 6), a suction and filtering unit, a driving position in the cabin (16) of the machine equipped with steer control members, and has the steer actuator of these members consisting of an electric motor (22). The sweeper also has the front steering axle (5) supported by arms of the suspension (20, 21) of which the upper ones (21) are arranged at a higher level than the maximum height of the wheel (18) of the same axle, the steer linkages (24, 25, 28) are also arranged at said upper-level; in the same way the lower arms (20) are shaped to receive said inner wheel in the position of maximum curvature; moreover, said container (13) is housed on a U-shaped plan rear axle (9).
The lung as a route for systemic delivery of therapeutic proteins and peptides

The large surface area, good vascularization, immense capacity for solute exchange and ultra-thinness of the alveolar epithelium are unique features of the lung that can facilitate systemic delivery via pulmonary administration of peptides and proteins. Physical and biochemical barriers, lack of optimal dosage forms and delivery devices limit the systemic delivery of biotherapeutic agents by inhalation. Current efforts to overcome these difficulties in order to deliver metabolic hormones (insulin, calcitonin, thyroid-stimulating hormone [TSH], follicle-stimulating hormone [FSH] and growth hormones) systemically, to induce systemic responses (immunoglobulins, cyclosporin A [CsA], recombinant-methionyl human granulocyte colony-stimulating factor [r-huG-CSF], pancreatic islet autoantigen) and to modulate other biological processes via the lung are reviewed. Safety aspects of pulmonary peptide and protein administration are also discussed.
Advantages of larval control for African malaria vectors: Low mobility and behavioural responsiveness of immature mosquito stages allow high effective coverage

Background
          Based on sensitivity analysis of the MacDonald-Ross model, it has long been argued that the best way to reduce malaria transmission is to target adult female mosquitoes with insecticides that can reduce the longevity and human-feeding frequency of vectors. However, these analyses have ignored a fundamental biological difference between mosquito adults and the immature stages that precede them: adults are highly mobile flying insects that can readily detect and avoid many intervention measures whereas mosquito eggs, larvae and pupae are confined within relatively small aquatic habitats and cannot readily escape control measures.
        
        
          Presentation of the hypothesis
          We hypothesize that the control of adult but not immature mosquitoes is compromised by their ability to avoid interventions such as excito-repellant insecticides.
        
        
          Testing the hypothesis
          We apply a simple model of intervention avoidance by mosquitoes and demonstrate that this can substantially reduce effective coverage, in terms of the proportion of the vector population that is covered, and overall impact on malaria transmission. We review historical evidence that larval control of African malaria vectors can be effective and conclude that the only limitations to the effective coverage of larval control are practical rather than fundamental.
        
        
          Implications of the hypothesis
          Larval control strategies against the vectors of malaria in sub-Saharan Africa could be highly effective, complementary to adult control interventions, and should be prioritized for further development, evaluation and implementation as an integral part of Rolling Back Malaria.
Compound 526666: methyl 4-(3-acetyloxy-10,13-dimethyl-2,3,4,5,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate

Chemical compound data from PubChem database. IUPAC Name: methyl 4-(3-acetyloxy-10,13-dimethyl-2,3,4,5,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate. Molecular Formula: C27H42O4. Molecular Weight: 430.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
National Household Survey on Drug Abuse (NHSDA-1982)

<p>This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, tobacco, and nonmedical use of prescription drugs among members of United States households aged 12 and older. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: cannabis, cocaine, hallucinogens, heroin, alcohol, tobacco, and nonmedical use of prescription drugs, including psychotherapeutics. Respondents were also asked about problems resulting from their use of drugs, alcohol, and tobacco, their perceptions of the risks involved, and personal and family income sources and amounts. Half of the respondents were asked questions regarding substance use by close friends. Demographic data include sex, race, age, ethnicity, educational level, job status, income level, veteran status, household composition, and population density. Youth respondents were also asked about time spent on homework and leisure activities. This study has 1 Data Set.</p>
Secondary Data Analysis From the National Survey on Child and Adolescent Well-Being

This webinar highlighted several research projects conducting secondary analysis on the National Survey on Child and Adolescent Well-Being (NSCAW), a study funded by ACF's Office of Planning Research and Evaluation (OPRE). This survey is a five-year longitudinal study of 5501 children who had contact with the child welfare system. Research using NSCAW data informs policy and practice in child welfare services and other services to maltreated children and their families, and advances the state of knowledge in child maltreatment, child welfare, child and family services, and/or child development for high-risk children.

Presenters: Barbara J. Burns, Ph.D., Duke University School of Medicine; Sandra Jee, Ph.D., University of Rochester Medical Center; and Dana Schultz, Ph.D., Rand Corporation

View the Webinar (WMV - 52MB)

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 527753: 2,2-Dichloroethyl decanoate

Chemical compound data from PubChem database. IUPAC Name: 2,2-dichloroethyl decanoate. Molecular Formula: C12H22Cl2O2. Molecular Weight: 269.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
The FFPSA Title IV-E Prevention Program Data Submission

The Family First Prevention Services Act (FFPSA) authorized new optional title IV-E funding for certain time-limited prevention services through creation of the title IV-E prevention program. On September 20, 2021 the Children’s Bureau hosted a webinar on Title IV-E Program Data Submission.

Descriptive Audio Version

Metadata-only record linking to the original dataset. Open original dataset below.
National Survey of Substance Abuse Treatment Services (N-SSATS-2009)

<p>The National Survey of Substance Abuse Treatment Services (N-SSATS) is designed to collect information from all facilities in the United States, both public and private, that provide substance abuse treatment. N-SSATS provides the mechanism for quantifying the dynamic character and composition of the United States substance abuse treatment delivery system. The objectives of N-SSATS are to collect multipurpose data that can be used to assist the Substance Abuse and Mental Health Services Administration (SAMHSA) and state and local governments in assessing the nature and extent of services provided and in forecasting treatment resource requirements, to update SAMHSA's Inventory of Substance Abuse Treatment Services (I-SATS), to analyze general treatment services trends, and to generate the National Directory of Drug and Alcohol Abuse Treatment Programs and its online equivalent, the Substance Abuse Treatment Facility Locator <a href="http://findtreatment.samhsa.gov">http://findtreatment.samhsa.gov</a>.  Data are collected on topics including facility operation, services offered (assessment and pretreatment, pharmacotherapies, testing, transitional, ancillary), detoxification, primary focus (substance abuse, mental health, both, general health, and other), hotline operation, Opioid Treatment Programs and medication dispensed/prescribed, counseling and therapeutic approaches, languages in which treatment is provided, type of treatment provided, number of clients (total and under age 18), number of beds, types of payment accepted, sliding fee scale, special programs offered, facility accreditation and licensure/certification, and managed care agreements.This study has 1 Data Set.</p>
Compound 525199: Chloromethyl 3-chloroheptanoate

Chemical compound data from PubChem database. IUPAC Name: chloromethyl 3-chloroheptanoate. Molecular Formula: C8H14Cl2O2. Molecular Weight: 213.1. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Utah (UT)

This report presents estimates for measures of substance use and mental health based on the combined 2010 and 2011 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for Utah for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
National Directory of Drug and Alcohol Abuse Treatment Facilities 2004

The National Directory of Drug and Alcohol Abuse Treatment Programs 2004 lists federal, state, local, and private facilities that provide substance abuse treatment services. The directory includes treatment facilities that are licensed, certified, or otherwise approved for inclusion in the directory by their state substance abuse agencies and that responded to the 2003 National Survey of Substance Abuse Treatment Services (N-SSATS). The information about each facility that appears in this directory was provided by that facility in response to the 2003 N-SSATS. The Substance Abuse and Mental Health Services Administration (SAMHSA) conducts the N-SSATS annually.
NNDSS - TABLE 1HH. Syphilis, Congenital to Syphilis, Primary and Secondary

NNDSS - TABLE 1HH. Syphilis, Congenital to Syphilis, Primary and Secondary – 2020.  In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
 Max: Maximum — Maximum case count during the previous 52 weeks.
* Case counts for reporting years 2019 and 2020 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf.
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
Mental Health Annual Report 2016

This report presents results from the Mental Health Client-Level Data (MH-CLD) and Mental Health Treatment Episode Data Set (MH-TEDS) for individuals receiving mental health treatment services in 2016, as well as selected trends in data collected from such individuals between 2013 and 2016. The report provides information on mental health diagnoses, mental health treatment services, and demographic and substance use characteristics of individuals in mental health treatment in facilities that reported to individual state administrative data systems.
Compound 525196: Phthalic acid, hexyl heptyl ester

Chemical compound data from PubChem database. IUPAC Name: 2-O-heptyl 1-O-hexyl benzene-1,2-dicarboxylate. Molecular Formula: C21H32O4. Molecular Weight: 348.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525679: p-Chlorobenzylidene-(3-methoxyphenyl)-amine

Chemical compound data from PubChem database. IUPAC Name: 1-(4-chlorophenyl)-N-(3-methoxyphenyl)methanimine. Molecular Formula: C14H12ClNO. Molecular Weight: 245.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E40162-T1: [Translated] FLEECE MADE OF PLASTIC FIBERS.

A felting of synthetic fibers having an embossed pattern that forms depressions in at least one surface of the felting is disclosed. The surface of the felting with depressions contains, in at least the area of the depressions, a layer of small hollow spheres that are bonded to one another and to the felting by means of a binding agent. The layer of hollow spheres fills up, at least partially, the depressions in the surface of the felting produced by embossing. This reinforces and strengthens the thinner areas of felting in the vicinity of these depressions. When the reinforced felting is applied to a shoe upper, for example, the resulting upper has improved stiffness and strength. Furthermore, the excessive penetration of adhesive into the felting, which can cause a spotty or uneven appearance of the reinforced upper, is prevented. Resistance to splitting and separating is likewise improved.
Compound 529787: Benzoic acid, 3,5-bis-(trifluoromethyl)phenylmethyl ester

Chemical compound data from PubChem database. IUPAC Name: [3,5-bis(trifluoromethyl)phenyl]methyl benzoate. Molecular Formula: C16H10F6O2. Molecular Weight: 348.24. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.